Oncternal Therapeutics To Sell Zilovertamab And ONCT-808 Programs To Hoola Therapeutics
1/7 14:26
(RTTNews) - Oncternal Therapeutics, Inc. (ONCT) announced the sale of its zilovertamab and ONCT-808 programs to Ho'ola Therapeutics, Inc....
1/7 14:26
(RTTNews) - Oncternal Therapeutics, Inc. (ONCT) announced the sale of its zilovertamab and ONCT-808 programs to Ho'ola Therapeutics, Inc....